Financials
Value Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 3.69 M9.31 M6.63 M8.48 M 28.12 M Research & development 19.64 M20.4 M17.32 M26.41 M 83.77 M Operating income -13.33 M-29.72 M-23.95 M-34.9 M -101.89 M Non-Operating Income, Total 1.72 M2.89 M4.56 M5.3 M 14.46 M Interest expense, net of interest capitalized 18 K15 K13 K24 K 70 K Non-Operating Income, excl. Interest Expenses 844 K1.43 M2.27 M2.63 M 7.17 M Unusual income/expense 853 K1.44 M2.28 M2.65 M 7.23 M Pretax income -11.61 M-68.87 M-19.4 M-29.62 M -129.5 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -12.47 M-28.27 M-21.67 M-32.25 M -94.67 M Discontinued operations ———— — Net income -12.47 M-28.27 M-21.67 M-32.25 M -94.67 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -12.47 M-28.27 M-21.67 M-32.25 M -94.67 M Basic earnings per share (Basic EPS) -8.0715.13-0.64-0.89 5.53 Diluted earnings per share (Diluted EPS) -8.0715.13-0.64-0.89 5.53 Average basic shares outstanding 1.55 M6.14 M33.67 M36.14 M — Diluted shares outstanding 1.55 M6.14 M33.67 M36.14 M — EBITDA -13.74 M-30.21 M-23.85 M-34.7 M -102.51 M EBIT -13.33 M-29.72 M-23.95 M-34.9 M -101.89 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) -415 K-499 K100 K200 K -614 K